The Patent Finder

Terms ending in 2035

Pharma Cinq, LLC

Every in-force patent on Pharma Cinq, LLC's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,175,295Antibodies and Methods for the Detection of Cell Death
In force
 · High confidence
PDL Biopharma, Inc.In forceHigh confidence
US 10,401,368Antibodies and Methods for the Detection of Cell Death
In force (reinstated)
 · High confidence
Pharma Cinq, LLCIn force (reinstated)High confidence
US 11,061,028Compositions and Methods for the Diagnosis of Lyme Disease
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Pharma Cinq, LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited